STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
ADMP ADAMIS PHARMACEUTICALS CORPORATION StockScouter® Report
2
StockScouter® Score
ADAMIS PHARMACEUTICALS CORPORATION, a micro cap value company in the healthcare sector, is expected to underperform the market over the next six months with slightly higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a small company like ADMP
Concerns
- Moving average analysis for ADMP suggests weak price movement over the medium term. Negative
- The enterprise value-to-sales ratio is higher than the average for comparably-sized companies in the StockScouter universe. Negative
- The multi-period measure of relative price change and consistency is below average. Negative/Neutral
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be out of favor, value stocks will be out of favor, and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
N/A
C
C
D